Implant-Based Slow Release of Molecules to Prevent Glioblastoma Recurrence

The article discusses a novel implantable wafer system called CANDI that delivers immunostimulatory small molecules to reprogram immunosuppressive myeloid cells in glioblastoma, leading to long-term survival and prevention of tumor recurrence in mouse models, with promising implications for human treatment.